Ipilimumab therapy for melanoma: A mimic of leptomeningeal metastases

American Journal of Neuroradiology

Volumn 36, Issue 12, 2015, Pages E69-E70

  Ali, S ^a   Lee, S K ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IPILIMUMAB;

BRAIN METASTASIS; BRAIN REGION; CANCER CHEMOTHERAPY; CELLULAR IMMUNITY; CRANIAL NEUROPATHY; HUMAN; LEPTOMENINGEAL METASTASIS; LETTER; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; SARCOIDOSIS; T LYMPHOCYTE;

EID: 84951078935     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4581     Document Type: Letter

References (3)

1. Keilholz U. CTLA-4: negative regulator of the immune response and a target for cancer therapy. J Immunother 2008;31:431-39 CrossRef Medline
2. Manousakis G, Koch J, Sommerville RB, et al. Multifocal radiculoneuropathy during ipilimumab treatment of melanoma. Muscle Nerve 2013;48:440-44 CrossRef Medline
3. Carpenter KJ, Murtagh RD, Lilienfeld H, et al. Ipilimumab-induced hypophysitis: MR imaging findings. AJNR Am J Neuroradiol 2009; 30:1751-53 CrossRef Medline